For type 2 diabetes mellitus. ANDA 75973, held by Mylan. Metformin Hydrochloride.
As of Nov 16, 2026, ANDA 75973 (Metformin Hydrochloride), held by Mylan, was first approved by FDA on Jan 25, 2002, with 11 approved supplements and 0 published complete response letters.
Metformin hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 25, 2002 | Original application | Approved | None posted |
| Metformin Hydrochloride500MG · tablet;oral | Metformin Hydrochloride | Rx |
| Metformin Hydrochloride850MG · tablet;oral | Metformin Hydrochloride | Rx |
| Metformin Hydrochloride1GM · tablet;oral | Metformin Hydrochloride | Rx |
| Aug 11, 2026 | Supplement 38Labeling · Standard review | Approved | None posted |
| Jun 4, 2024 | Supplement 36Manufacturing | Approved | None posted |
| Jan 14, 2019 | Supplement 19Labeling · Standard review | Approved | None posted |
| Jan 14, 2019 | Supplement 20Labeling · Standard review | Approved | None posted |
| Jun 17, 2014 | Supplement 11Labeling | Approved | None posted |
| Feb 9, 2012 | Supplement 15Manufacturing | Approved | None posted |
| Feb 29, 2008 | Supplement 9Labeling | Approved | None posted |
| Jun 13, 2007 | Supplement 8Labeling | Approved | None posted |
| May 11, 2005 | Supplement 5Labeling | Approved | None posted |
| Oct 11, 2002 | Supplement 2Labeling | Approved | None posted |
| Apr 11, 2002 | Supplement 1Labeling | Approved | None posted |
| Jan 25, 2002 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters